Succinylcholine chloride (SCh) is hydrolysed by plasma cholinesterase (ChE, EC 3.1.1.8). ~ It is generally accepted that the short duration of action of succinylcholine is due to a rapid enzymatic hydrolysis by ChE. The duration of action of SCh has been shown to be dependent on the activity of plasma ChE. 2 ChE was electrophoretically separated to four isoenzymes Ci, C2, C3 and C4. In addition to these four, a fifth slower moving component was found in some individuals, who were labelled C5 positive (C5 +) variants, while individuals who lack the component were labelled C5 negative (Cf) variants. 3 Sera containing C5 usually have relatively high ChE activity: Though it is logical to speculate that Cs + individuals have a shorter duration of action of succinylcholine than those who are C5-, no investigation has been reported concerning the role of the ChE isozyme in determining responsiveness to succinylcholine.
The purpose of present study was to determine whether patients with the C5 isozyme have a shortened duration of action of succinylcholine and to quantify the relationship between duration of succinylcholine neuromuscular blockade and the plasma ChE C5 isozyme.
Methods
Four hundred and ninety one adult patients, 267 men and 224 women, undergoing elective surgery were studied. Informed consent was obtained from each patient and the study was approved by the hospital ethics committee. Blood samples for detection of the ChE C5 component were withdrawn at the preanaesthetic examination. Presence or absence of the ChE C5 component was established by electrophoresis. Electrophoresis of sera was performed using a miniaturized electrophoretic appara-tus which was custom-made, according to specifications previously published, s Electrophoresis was carried out essentially as described by Davis. 6 (See Appendix for details.) Scanning profiles were obtained after applying the gels to a densitometer.
ChE activity was assayed spectrophotometrically in a Hitachi 200-20 recording spectrophotometer by the method of Kalow and Lindsay 7 which is based on the rate of hydrolysis of benzoylcholine in M/I 5 phosphate buffer pH 7.4 at 25 ~ C which is followed by decrease in absorbance at 240 nm. Serum at a dilution of 1:50 was used as the source of enzyme, the final dilution in the reaction mixture being 1:100. Dibucaine and fluoride numbers were determined as described by Kalow and Genest 8 and Harris and Whittaker 9 respectively.
Eighteen C5 negative patients who were randomly selected from the Cs negative patients of ASA p h y s i c a l status I or II a n d all o f 12 C5 positive patients of ASA physical status I or II (all of whom had normal ChE genotypes (dibucaine number and fluoride number)), were entered in the study of neuromuscular blockade and measurement of ChE activity. For all tests of ChE activity, dibucaine and fluoride numbers, and monitoring of neuromuscular blockade, the observers were unaware of the Csand C5 + identity of individual patients.
Premedication consisted of 0.4-0.5 mg atropine IM and 50 mg hydroxyzine IM 45-60 min before induction of anaesthesia. A blood sample to be used for measurement of ChE activity was withdrawn, and an intravenous infusion was started when the patient arrived in the operating room. Anaesthesia was induced with thiamylal 4-5 mg-kg-i and maintained with 66 per cent nitrous oxide in oxygen and additional thiamylal. Respiration was assisted, if required, but hyperventilation was avoided by measuring arterial blood gases periodically, in addition to serum electrolytes, and serum pH. Body temperature was measured by rectal probe inserted before induction of anaesthesia.
After induction of anaesthesia, the ulnar nerve was stimulated at the wrist with a series of four supramaximal single stimuli (square wave pulses of 0.2 msec duration) delivered at 0.1 Hz (train-offour) from a peripheral nerve stimulator (Myotest, Biometer Ltd., Denmark) using surface electrodes. The evoked force of contraction of the adductor pollicis was measured and recorded using a force transducer and a neuromuscular function analyzer (Myograph 2000, Biometer Ltd., Denmark) as described by Viby-Mogensen. 1o
When the response to the train-of-four stimulation was stable, the height of the first twitch of the train was taken as the standard control (control twitch height). Succinylcholine, 40mg/m 2 body surface area, was given intravenously as quickly as possible. Monitoring of neuromuscular transmission was continued after succinylcholine administration, at least until the height of the first twitch of the train had returned to the control twitch height 50, and 80 per cent recovery of control twitch height were determined in each case.
Statistical significance was estimated with an unpaired t-test.
Results
Electrophoresis of sera of patients demonstrated zymograms of ChE as in Figure 1 . 3 It has been shown that the C4 band contributes the greatest portion of ChE activity, and the C5 component -if present -contains the second largest portion of ChE activity in the C5 + enzyme as demonstrated by densitometry (Figure 2) .
Both groups of patients were comparable with respect to sex, age, weight, height, and body surface area (Table I) . Twenty-four of the 491 (4.9 per cent) patients studied were positive for the C5 isozyme. Nine were positive for the ChE C5 isozyme among the 267 males, and 15 of 224 females were ChE C5 positive.
Plasma cholinesterase activity in the C5 + group was significantly higher than the C5-group. Patients whose sera contain the C5 component had 30.1 per cent more ChE activity than those without this component. Dibucaine and fluoride numbers were within normal limits in all the patients who had ChE activity measured (Table II) .
The pattern of neuromuscular blockade was characteristic of a depolarizing block in all cases. The duration of neuromuscular blockade by succinylcholine was significantly shorter in Cs + patients than C5-patients (Table 11I ). Average times 
Discussion
Harris et al. 3 described the appearance and enzymatic behaviour of serum ChE in normal serum as seen after two dimensional electrophoresis, first on paper and then on starch gel. Four components of serum ChE activity were found in the gels, corresponding to at least four isozymes which have been designated as C~, C2, C3, and C4, according to the decreasing order of mobility toward the anode. The slowest component (C,0 is the major enzyme, containing most of the serum ChE activity. Harris et al. found a fifth slower-moving component, in a few sera. This component was designated the C5 component. Our experiments clearly demonstrate that the C5 isozyme can be separated from other isozymes of ChE by electrophoresis with polyacrylamide. Harris et al. ~ provided evidence that the gene which determines the occurrence of C5 is non-allelic to the genes on El locus which control the bands CI-C4. Robson et al.I2 supported this hypothesis. This second gene has been designated the E2 + gene) 3 The incidence of the C5 variant in our patient population (all Japanese) was 4.9 per cent. The frequency of the C5 variant in various populations was found to vary from 0.3 per cent to 10.1 per cent by Steegmtiller. 14 She also reviewed the incidence of the C5 variant in various populations as found by others, with values of 0 to 29 per cent reported. The calculated incidence of the C5 variant was 9.4 per cent among Mongoloids (included 47 Koreans and 81 Thais). The number of samples tested was likely too few to give a reliable incidence. A possible explanation for the variations noted is that electrophoretic methods used by most authors are not sensitive enough to detect all patients with the C5 + phenotypes. Simpson js demonstrated that a polyacrylamide gel electrophoretic system (2.5 per cent acrylamide spacer gel, pH6.7; seven per cent separating gel, pH 8.9) was able to detect 25 per cent more C5 + individuals than a 15 per cent starch gel system at pH5.3. However Singh et al. ~6 maintained that in their material the method described by Simpson did not help to detect any misclassification produced by the starch gel method.
The results of this study show that C5 positive variants have 30 per cent more plasma ChE activity than those without this component. This is in accordance with the results of Harris et al, 4 who reported that subjects whose sera contained the Cs component usually have 30 per cent more plasma eholinesterase activity than those without this component.
The duration of action of succinylcholine was about 30 per cent less in C5 + individuals than in Csindividuals, when it was administered on the basis of body surface area. Earlier studies have examined the correlation between the Cb.E level and duration of action of succinylcholine. Some found good correlations between the esterase level and duration of apnoea I7-24 while others found only partial correlation or no correlation. 25 '26 In none of these studies was neuromuscular function monitored. In addition, few of the studies investigated the ChE phenotype and none determined the ChE C5 isozyme.
Viby-Mogensen z reported that for patients with the geotypically normal enzyme the duration of suecinylcholine action measured by the duration of apnoea and the time to 100 per cent recovery of twitch height (train-of-four) increased with the decreasing plasma ChE activity. He did not investigate the ChE isozyme for detection of the C5 variant, though he determined dibucaine, fluoride, chloride, scoline, and urea numbers. Neitlich 27 reported a genetic variant that increased the serum ChE two to three times the normal mean value with the appearance of a slow-moving band on zymograms obtained by disc-electrophoresis with acrylamide gels as the supporting medium. This variant was associated with resistance to succinylcholine in grip strength. Yoshida and Motulsky 2s showed the increased enzyme activity of the variant described by Neitlich could be attributed to an increase in the number of enzyme molecules. They concluded that the variant enzyme has approximately the same specific enzyme activity as normal and that the extra enzyme component of the variant plasma is structurally different from the C5 enzyme component. They named the variant E. cynthiana. Blitt et al. 29 showed no correlation between plasma ChE activity and duration of paralysis from succinylcholine using single-twitch nerve stimulation. This is probably because Blitt's patients showed only minor variations in enzymatic activity. High plasma ChE activity was detected in two German families by Delbrtick et al. a~ They 3z showed that the ChE of the propositi exhibited isozyme separation patterns in polyacrylamide electrophoresis as well as in electrofocusing which were different from those of ChE from normal persons, but no differences could be seen with respect to the Km for substrates or the inhibition by dibucaine, fluoride or succinylcholine.
Scott et al 3z showed the properties of the C5 + enzyme to differ from the principal serum ChE in only minor ways. Muensch et al. 33 observed no difference at esteratic site of the enzyme with C5 component from the normal enzyme without C5. Therefore the difference in sensitivity to suecinylcholine between C5-and C5 + variants probably results from the difference in quantity of ChE activity.
The results of our study indicate that the ChE Cs isozyme, a genetic factor determined by the presence of the EE + gene, contributes to decreased neuromuscular sensitivity to succinylcholine.
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